ArticleMolecular pharmaceutics2024

Nanoencapsulation of MDM2 Inhibitor RG7388 and Class-I HDAC Inhibitor Entinostat Enhances their Therapeutic Potential Through Synergistic Antitumor Effects and Reduction of Systemic Toxicity.

Anas Abed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.